The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
APPLIED MOLECULAR TRANS INC | COM | 03824M109 | 111,129 | 3,611,615 | SH | SOLE | 3,611,615 | 0 | 0 | ||
PALO ALTO NETWORKS INC | COM | 697435105 | 19,882 | 55,944 | SH | SOLE | 55,944 | 0 | 0 | ||
TILRAY INC | COM CL 2 | 88688T100 | 5,008 | 606,350 | SH | SOLE | 606,350 | 0 | 0 | ||
UBER TECHNOLOGIES INC | COM | 90353T100 | 253,220 | 4,965,103 | SH | SOLE | 4,965,103 | 0 | 0 | ||
UNITY BIOTECHNOLOGY INC | COM | 91381U101 | 2,577 | 491,751 | SH | SOLE | 491,751 | 0 | 0 |